Policy / Pricing UK partners with Eli Lilly on obesity plan PharmaphorumThe UK has teamed up with Eli Lilly on initiatives, backed with 85 million in funding, to expand access to treatment for obesity.Metabolic & GLP-1Read full story pharminent June 29, 2026 (Last updated: June 29, 2026) Pharmaphorum The UK has teamed up with Eli Lilly on initiatives, backed with 85 million in funding, to expand access to treatment for obesity. Metabolic & GLP-1 Read full story Post navigation Previous: Zymeworks cuts deal to buy Theravance for $929m in cashNext: Viridian’s Lumvoa Wins FDA Approval, Taking Direct Aim at Amgen’s Tepezza in Thyroid Eye Disease Related Stories Policy / Pricing Mid-cap biotechs join Trump’s latest round of drug pricing deals pharminent September 1, 2026 Policy / Pricing MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones pharminent August 27, 2026 Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026